{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T02:19:37Z","timestamp":1773973177470,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":69,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011421","name":"Sanofi China Investment Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011421","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.transproceed.2025.11.002","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T12:32:57Z","timestamp":1768221177000},"page":"28-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Thymoglobulin Induction Therapy in Kidney Transplant Patients Receiving Organs Donated after Cardiac Death in China: A Real-World Patient-Level Pooled Analysis of the T-DCD and Start-DCD Studies"],"prefix":"10.1016","volume":"58","author":[{"given":"Yang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wujun","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2025.11.002_bib0001","series-title":"Annual data report: Epidemiology of Kidney Disease in the United States","article-title":"United States Renal Data System","year":"2019"},{"issue":"1","key":"10.1016\/j.transproceed.2025.11.002_bib0002","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1038\/s41598-022-06452-9","article-title":"Barriers to the donation of living kidneys for kidney transplantation","volume":"12","author":"Min","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.transproceed.2025.11.002_bib0003","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.eclinm.2018.09.007","article-title":"Equivalent long-term transplantation outcomes for kidneys donated after brain death and cardiac death: conclusions from a nationwide evaluation","volume":"4-5","author":"Schaapherder","year":"2018","journal-title":"EClinicalMedicine"},{"issue":"10","key":"10.1016\/j.transproceed.2025.11.002_bib0004","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1097\/TP.0b013e3181f83b0b","article-title":"Kidney transplantation from donors after cardiac death: a 25-year experience","volume":"90","author":"Snoeijs","year":"2010","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.transproceed.2025.11.002_bib0005","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/ki.2015.88","article-title":"Kidney donation after circulatory death (DCD): state of the art","volume":"88","author":"Summers","year":"2015","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.transproceed.2025.11.002_bib0006","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13190","article-title":"The impact of kidney donor profile index on delayed graft function and transplant outcomes: a single-center analysis","volume":"32","author":"Zens","year":"2018","journal-title":"Clin Transplant"},{"issue":"5","key":"10.1016\/j.transproceed.2025.11.002_bib0007","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/ajt.12190","article-title":"Kidney transplantation from donors after cardiac death: an initial report of 71 cases from China","volume":"13","author":"Chen","year":"2013","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.transproceed.2025.11.002_bib0008","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/ajt.15098","article-title":"Enhanced immunosuppression improves early allograft function in a porcine kidney transplant model of donation after circulatory death","volume":"19","author":"Xu","year":"2019","journal-title":"Am J Transplant"},{"issue":"10","key":"10.1016\/j.transproceed.2025.11.002_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0240929","article-title":"Induction therapy in kidney transplant recipients: description of the practices according to the calendar period from the French multicentric DIVAT cohort","volume":"15","author":"Boucquemont","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.transproceed.2025.11.002_bib0010","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12882-019-1293-2","article-title":"Induction therapy with thymoglobulin or interleukin-2 receptor antagonist for Chinese recipients of living donor renal transplantation: a retrospective study","volume":"20","author":"Qiu","year":"2019","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.transproceed.2025.11.002_bib0011","doi-asserted-by":"crossref","unstructured":"Neuwirt H, Rudnicki M, Schratzberger P, Pirklbauer M, Kronbichler A, Mayer G. Immunosuppression after renal transplantation. Memo 2019;12(3):216\u201321. doi:10.1007\/s12254-019-0507-4","DOI":"10.1007\/s12254-019-0507-4"},{"issue":"6","key":"10.1016\/j.transproceed.2025.11.002_bib0012","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/ki.2014.188","article-title":"A useful scoring system for the prediction and management of delayed graft function following kidney transplantation from cadaveric donors","volume":"86","author":"Chapal","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2025.11.002_bib0013","article-title":"Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients","volume":"1","author":"Hill","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.transproceed.2025.11.002_bib0014","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1365-2362.2011.02490.x","article-title":"Long-term outcome of ATG vs. basiliximab induction","volume":"41","author":"Ulrich","year":"2011","journal-title":"Eur J Clin Invest"},{"issue":"12","key":"10.1016\/j.transproceed.2025.11.002_bib0015","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1097\/00007890-200112270-00008","article-title":"Basiliximab versus antithymocyte globulin for prevention of acute renal allograft rejection","volume":"72","author":"Sollinger","year":"2001","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.transproceed.2025.11.002_bib0016","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.2215\/CJN.08710814","article-title":"Induction therapies in live donor kidney transplantation on tacrolimus and mycophenolate with or without steroid maintenance","volume":"10","author":"Tanriover","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.transproceed.2025.11.002_bib0017","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1159\/000351643","article-title":"Thymoglobulin and its use in renal transplantation: a review","volume":"37","author":"Thiyagarajan","year":"2013","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.transproceed.2025.11.002_bib0018","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/00007890-201407151-01956","article-title":"Comparison of efficacy and safety of different induction therapies in kidney transplantation from donation after cardiac death.: Abstract# C1799","volume":"98","author":"Chen","year":"2014","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.transproceed.2025.11.002_bib0019","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.ekir.2022.01.1042","article-title":"Thymoglobulin versus alemtuzumab versus basiliximab kidney transplantation from donors after circulatory death","volume":"7","author":"Asderakis","year":"2022","journal-title":"Kidney Int Rep"},{"issue":"3","key":"10.1016\/j.transproceed.2025.11.002_bib0020","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.transproceed.2020.01.054","article-title":"Low-dose thymoglobulin vs basiliximab induction therapy in low-risk living related kidney transplant recipients: a prospective randomized trial","volume":"53","author":"Martinez-Mier","year":"2021","journal-title":"Transplant Proc"},{"issue":"5","key":"10.1016\/j.transproceed.2025.11.002_bib0021","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/TP.0000000000000469","article-title":"Peak panel reactive antibody, cancer, graft, and patient outcomes in kidney transplant recipients","volume":"99","author":"Lim","year":"2015","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.transproceed.2025.11.002_bib0022","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/tan.12147","article-title":"Ceppellini Lecture 2012: Collateral damage from HLA mismatching in kidney transplantation","volume":"82","author":"Opelz","year":"2013","journal-title":"Tissue Antigens"},{"issue":"4","key":"10.1016\/j.transproceed.2025.11.002_bib0023","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.trim.2012.02.003","article-title":"The effect of low and ultra-low dosages of thymoglobulin on peripheral T, B and NK cells in kidney transplant recipients","volume":"26","author":"Kho","year":"2012","journal-title":"Transpl Immunol"},{"issue":"8","key":"10.1016\/j.transproceed.2025.11.002_bib0024","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1432-2277.2006.00270.x","article-title":"Comparison of two dosages of thymoglobulin used as a short-course for induction in kidney transplantation","volume":"19","author":"Wong","year":"2006","journal-title":"Transpl Int"},{"issue":"1","key":"10.1016\/j.transproceed.2025.11.002_bib0025","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/ajt.13884","article-title":"Induction therapy for kidney transplant recipients: do we still need anti-IL2 receptor monoclonal antibodies?","volume":"17","author":"Hellemans","year":"2017","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.transproceed.2025.11.002_bib0026","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.12977","article-title":"The appropriate dose of thymoglobulin induction therapy in kidney transplantation","volume":"31","author":"Nafar","year":"2017","journal-title":"Clin Transplant"},{"issue":"12","key":"10.1016\/j.transproceed.2025.11.002_bib0027","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1097\/TP.0b013e3182708e30","article-title":"Influence of delayed graft function and acute rejection on outcomes after kidney transplantation from donors after cardiac death","volume":"94","author":"Nagaraja","year":"2012","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.transproceed.2025.11.002_bib0028","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1111\/ajt.13191","article-title":"Daclizumab versus rabbit antithymocyte globulin in high-risk renal transplants: five-year follow-up of a randomized study","volume":"15","author":"Hellemans","year":"2015","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.transproceed.2025.11.002_bib0029","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1399-0012.2010.01241.x","article-title":"Kidney transplantation from donation after cardiac death donors: lack of impact of delayed graft function on post-transplant outcomes","volume":"25","author":"Singh","year":"2011","journal-title":"Clin Transplant"},{"issue":"10","key":"10.1016\/j.transproceed.2025.11.002_bib0030","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1016\/j.transproceed.2010.10.003","article-title":"Impact of age matching of donors to recipients on renal transplant outcomes following donation after cardiac death","volume":"42","author":"Pine","year":"2010","journal-title":"Transplant Proc"},{"issue":"4","key":"10.1016\/j.transproceed.2025.11.002_bib0031","doi-asserted-by":"crossref","first-page":"673","DOI":"10.4103\/1319-2442.113846","article-title":"Impact of donor age on outcome of kidney transplantation from controlled donation after cardiac death","volume":"24","author":"Akoh","year":"2013","journal-title":"Saudi J Kidney Dis Transplant"},{"issue":"1","key":"10.1016\/j.transproceed.2025.11.002_bib0032","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1600-6143.2007.02014.x","article-title":"Prospective age-matching in elderly kidney transplant recipients: a 5-year analysis of the Eurotransplant Senior Program","volume":"8","author":"Frei","year":"2008","journal-title":"Am J Transplant"},{"issue":"12","key":"10.1016\/j.transproceed.2025.11.002_bib0033","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1097\/00007890-199712270-00022","article-title":"Risk factors for renal allograft survival from older cadaver donors","volume":"64","author":"Hariharan","year":"1997","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.transproceed.2025.11.002_bib0034","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/ndt\/15.5.696","article-title":"Age-matching in renal transplantation","volume":"15","author":"Waiser","year":"2000","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"10.1016\/j.transproceed.2025.11.002_bib0035","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1111\/j.1600-6143.2007.01852.x","article-title":"Outcomes of kidneys from donors after cardiac death: implications for allocation and preservation","volume":"7","author":"Locke","year":"2007","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.transproceed.2025.11.002_bib0036","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.transproceed.2017.03.064","article-title":"Influence of long-term dialysis on the outcome of kidney transplantation: a single-center study","volume":"49","author":"Masaki","year":"2017","journal-title":"Transplant Proc"},{"issue":"1","key":"10.1016\/j.transproceed.2025.11.002_bib0037","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/ndt\/gfh541","article-title":"Duration of end-stage renal disease and kidney transplant outcome","volume":"20","author":"Goldfarb-Rumyantzev","year":"2005","journal-title":"Nephrol Dial Transplant"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134525005858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134525005858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T01:37:53Z","timestamp":1773970673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134525005858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0041134525005858"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2025.11.002","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thymoglobulin Induction Therapy in Kidney Transplant Patients Receiving Organs Donated after Cardiac Death in China: A Real-World Patient-Level Pooled Analysis of the T-DCD and Start-DCD Studies","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2025.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}